Prediction of Gastric Cancer Metastasis through Urinary Metabolomic Investigation using GC/MS
News Jul 16, 2012
Human gastric cancer SGC-7901 cells were implanted into 24 severe combined immune deficiency (SCID) mice, which were randomly divided into metastasis group (n = 8), non-metastasis group (n = 8), and normal group (n = 8). Urinary metabolomic information was obtained by gas chromatography/mass spectrometry (GC/MS).
There were significant metabolic differences among the three groups (t test, P < 0.05). Ten selected metabolites were different between normal and cancer groups (non-metastasis and metastasis groups), and seven metabolites were also different between non-metastasis and metastasis groups. Two diagnostic models for gastric cancer and metastasis were constructed respectively by the principal component analysis (PCA). These PCA models were confirmed by corresponding receiver operating characteristic analysis (area under the curve = 1.00).
The urinary metabolomic profile is different, and the selected metabolites might be instructive to clinical diagnosis or screening metastasis for gastric cancer.
The article is published online in the World Journal of Gastroenterology and is free to access.
Technology Allows Inexpensive Extraction of Rare Earth ElementsNews
New efficient and inexpensive technologies could allow the extraction of rare earth elements, critical components of many electronics and green products, from waste coal ash.READ MORE
Advantage of Breastfeeding to Increase Mother-Child BondNews
Researchers have found that the molecule RAGE, on the intestinal epithelium, transports oxytocin into the blood even after neonate gut closure. This finding suggests breastfeeding and oral oxytocin administration is advantageous to increase its concentration in blood and mother-child bond.READ MORE
Biomarker for Glioblastoma Predicts Clinical Course and Sensitivity to TreatmentNews
Scientists validate a biomarker indicative of patients with Glioblastoma prognosis and likely response to specific therapies.READ MORE